Editor’s note: A recording of this conversation is embedded below.
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma and health tech leaders. This week, Pharmalot columnist, Ed Silverman, is joined by former executive vice president and chief commercial officer of Gilead Sciences, Jim Meyers. Together they will discuss all things drug pricing, policy, and access, and of course, be taking your questions live.
About the Author Reprints
